greeksoup/ stock research
Stock research / United States / GSK / Year to 31 December 2023

GSK plc (GSK) annual results, year to 31 December 2023: revenue GBP 30,328 million, from the 20-F

GSK plc files a 20-F with the SEC once a year, in pounds sterling. In the year to 31 December 2023 it reported revenue of GBP 30,328 million ($37.7 billion at the year's average rate), up 3.4% on the year before. Its profit attributable to shareholders was GBP 4,928 million, down 67.1%, and diluted earnings per share GBP 1.20.

Revenue
GBP 30,328 million
+3.4% on the year
FY2016FY2023
Operating margin
22.2%
21.9% a year earlier
FY2016FY2023
Net income
GBP 4,928 million
-67.1% on the year
FY2016FY2023
Diluted EPS
GBP 1.20
-67.3% on the year
FY2016FY2023

this yearthe year beforeIn pounds sterling as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2022Dec 2023
Revenue29,32430,328
Cost of sales9,5548,565
Gross profit19,77021,763
Research and development5,4886,223
Selling, general and administrative8,3729,385
Operating profit6,4336,745
Finance costs879792
Profit before tax5,6286,064
Income tax707756
Profit for the year15,6215,308
Profit attributable to shareholders14,9564,928
Filing20-F20-F
GBP million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2022Dec 2023
Diluted EPS3.661.20
Basic EPS3.711.22
Filing20-F20-F

GBP per ordinary share, as filed.

Cash flow

Year toDec 2022Dec 2023
Cash from operations7,4036,768
Purchase of property, plant and equipment1,1431,314
Free cash flow6,2605,454
Cash from investing-8,772-1,595
Cash from financing823-5,641
Depreciation and amortisation2,1472,294
Buybacksn/a0.0
Dividends paid3,4672,247
Filing20-F20-F

GBP million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2022Dec 2023
Funded by
Equity attributable to shareholders10,59813,347
Non-controlling interests-502-552
Borrowings, as filed20,98718,018
Lease liabilities1,0081,207
Other liabilities28,05526,985
Total equity and liabilities60,14659,005
Owned
Property, plant and equipment8,9339,020
Goodwill7,0466,811
Other intangible assets14,31814,768
Cash and cash equivalents3,7232,936
Trade and other receivables7,0537,385
Inventories5,1465,498
Other assets13,92712,587
Total assets60,14659,005
Filing20-F20-F

GBP million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2022Dec 2023
Gross margin67.4%71.8%
Operating margin21.9%22.2%
Net margin51.0%16.2%
Free cash flow margin21.3%18.0%
Return on year-end equity141.1%36.9%
Effective tax rate12.6%12.5%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2023, filed 3 March 2025: the filing. The figures are in pounds sterling as filed.